Delivery Order SPE2DR25D1017-SPE2DR26F9BXB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,967.57 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency (DLA) awarded a $10,932.36 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count) on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count) at a firm fixed price of $5,740.94, with completion due by November 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,358.35 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Entresto 24 mg-26 mg, a pharmaceutical product used to treat heart failure. This competitive award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price transaction with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) valued at $2,151.36. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,453.82 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-competitive award to support federal pharmaceutical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) valued at $1,412.73, with an ultimate completion date of June 5, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price terms and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BXBDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,650.00 for Entresto 24 mg-26 mg tablets (180 count) on December 22, 2025, with completion scheduled for December 23, 2025. This competitive award, executed without a set-aside designation, represents a firm fixed-price delivery order for a heart failure medication to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.9 million through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply an extensive range of medications, vaccines, and medical supplies to support military and federal healthcare systems globally. The delivery order represents one of numerous competitively awarded transactions under this IDC vehicle, demonstrating AmerisourceBergen's role as a critical pharmaceutical distributor for Department of Defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/21/25 |